Cargando…

Imaging in Carcinoma Cervix and Revised 2018 FIGO Staging System: Implications in Radiology Reporting

The International Federation of Gynecology and Obstetrics (FIGO) staging system of carcinoma cervix saw a radical change in 2018 with the inclusion of cross-sectional imaging tools for the assessment of disease extent and staging. One of the major revisions is the inclusion of lymph node status, det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhamija, Ekta, Gulati, Malvika, Manchanda, Smita, Singhal, Seema, Sharma, Dayanand, Kumar, Sunesh, Bhatla, Neerja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590564/ https://www.ncbi.nlm.nih.gov/pubmed/34790308 http://dx.doi.org/10.1055/s-0041-1735502

Ejemplares similares

Implications of the revised cervical cancer FIGO staging system
por: Bhatla, Neerja, et al.
Publicado: (2021)

Radiological evaluation of metastatic lymph nodes in carcinoma cervix with emphasis on their infiltrative pattern
por: Dhamija, Ekta, et al.
Publicado: (2021)

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
por: Berek, Jonathan S., et al.
Publicado: (2018)

FIGO staging for carcinoma of the vulva: 2021 revision
por: Olawaiye, Alexander B., et al.
Publicado: (2021)

Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009
por: Zhang, Yunqiang, et al.
Publicado: (2022)

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020)

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix
por: Mann, Minakshi, et al.
Publicado: (2019)

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
por: Kasamatsu, T, et al.
Publicado: (2009)

Cancer of the cervix uteri: 2021 update
por: Bhatla, Neerja, et al.
Publicado: (2021)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001)

The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care
por: Bhatla, Neerja, et al.
Publicado: (2020)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

Prognostic factors and treatment of neuroendocrine tumors of the uterine cervix based on the FIGO 2018 staging system: a single-institution study of 172 patients
por: Chen, Jian, et al.
Publicado: (2021)

Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging
por: Virarkar, Mayur, et al.
Publicado: (2022)

A Cross-Sectional Analysis to Evaluate Knowledge, Attitude And Practices Among Pregnant Women During COVID-19 Pandemic
por: Kaur, Tarang P., et al.
Publicado: (2021)

Can portable Colposcopes Replace Standard-of-care Colposcopes? A Crossover Trial of Two Portable Colposcopes with a Standard-of-Care Video Colposcope
por: Natarajan, Jayashree, et al.
Publicado: (2022)

Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway
por: Das, Abhijit, et al.
Publicado: (2023)

Early-Stage epithelial ovarian cancer: Predictors of survival
por: Upadhyay, Avinash, et al.
Publicado: (2022)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

Imaging and Pathological Features of Alveolar Soft Part Sarcoma: Analysis of 16 Patients
por: Gulati, Malvika, et al.
Publicado: (2021)

The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status
por: Zhou, Juan, et al.
Publicado: (2016)

FIGO Staging for Uterine Sarcomas: Can the Revised 2008 Staging System Predict Survival Outcome Better?
por: Yim, Ga Won, et al.
Publicado: (2014)

High-dose-rate interstitial brachytherapy for female peri-urethral cancer
por: Sharma, Daya Nand, et al.
Publicado: (2016)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Indications for endoscopy according to the revised FIGO staging for cervical cancer after MRI and CT scanning
por: Jeong, Bae Kwon, et al.
Publicado: (2012)

자궁경부암: 개정된 2018 FIGO 병기와 자기공명영상을 중심으로
Publicado: (2021)

Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix
por: Shen, Ting, et al.
Publicado: (2019)

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
por: Yang, Xi, et al.
Publicado: (2020)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors
por: Yan, Ding-Ding, et al.
Publicado: (2019)

Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
por: Qin, Fengying, et al.
Publicado: (2022)

Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Oncologic and reproductive outcomes of borderline ovarian tumors in Indian population
por: Kumari, Sarita, et al.
Publicado: (2021)

Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis
por: Sharma, Aparna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j3c7l50d351qfh5gpte8oasg5j